Dosage Charts Calculator Blends & Stacks Learn Blog Peptides
Open Calculator
Blog  ›  AOD-9604: What It Is, What Research Shows, and Dosage

AOD-9604: What It Is, What Research Shows, and Dosage

Jun 11, 2026 4 min Metabolic
TL;DR
AOD-9604 is a synthetic peptide fragment originally developed as a potential obesity treatment. Early clinical trials showed some promise for fat metabolism, but human evidence remains limited. Researchers are now also exploring its role in musculoskeletal repair, though rigorous clinical data is still scarce.

What Exactly Is AOD-9604?

Think of human growth hormone (HGH) as a long sentence. AOD-9604 is just one short phrase clipped from the end of that sentence — specifically, amino acids 176 to 191 of the HGH protein. Scientists call it a peptide fragment. "Peptide" just means a short chain of amino acids, the building blocks of proteins.

The interesting thing about this particular fragment is that it appears to mimic the fat-burning effects of HGH without some of the other hormonal activity. That made it an attractive research candidate early on.[1]

Why Did Researchers Start Studying It?

The original motivation was obesity. A pharmaceutical company began developing AOD-9604 as a potential treatment for people carrying excess body fat. By early 2002, the compound had already entered Phase IIa clinical trials — meaning it was being tested in a small group of humans for the first time.[1] That same period also saw it listed among notable drugs entering clinical investigation.[6]

The core idea: could you get fat-loss benefits from a tiny HGH fragment without triggering the growth-promoting or blood-sugar-raising effects of the full hormone? Early animal and cell studies were encouraging enough to push it into human trials.

What Does the Research Actually Show?

Fat Metabolism

The early clinical work suggested AOD-9604 could influence how the body breaks down fat — a process called lipolysis. The compound appeared to stimulate fat breakdown and inhibit new fat formation.[1] However, larger Phase IIb trials examining weight loss in obese patients did not produce the dramatic results researchers hoped for, and the obesity program was eventually discontinued. The human evidence here is limited and dates back over two decades.

Musculoskeletal and Tissue Repair

More recently, sports medicine and orthopaedic researchers have turned their attention to peptides — including AOD-9604 — as potential tools for healing injuries. A 2026 review in the Journal of the American Academy of Orthopaedic Surgeons noted that growth hormone secretagogues like AOD-9604 may activate IGF-1 signalling and satellite cell repair, processes important for muscle and tissue recovery.[2] "Satellite cells" are the stem cells of muscle — they patch up damage after injury or hard training.

A separate 2026 sports medicine review examined AOD-9604 alongside other unapproved peptides marketed to athletes and patients seeking faster recovery. The authors noted that while animal models show favorable outcomes for tissue repair and metabolism, rigorous human safety data are scarce, and there is potential for harm.[4] In plain English: promising in labs and animal studies, not yet proven in well-designed human trials.

Anti-Doping and Detection

Because AOD-9604 is structurally related to HGH, anti-doping authorities have paid close attention to it. Research confirmed that AOD-9604 does not trigger a positive result on the World Anti-Doping Agency (WADA) standard growth hormone immunoassay test.[3] That means the routine HGH doping test won't catch it. However, mass spectrometry — a more sensitive detection technique used in advanced doping control labs — is capable of identifying peptide-based compounds in athlete samples.[5] AOD-9604 remains a banned substance under WADA rules.

Where Does That Leave Us?

Here is an honest summary of the evidence landscape:

  • Animal studies: Fairly consistent signals for fat metabolism effects and some tissue-repair activity.
  • Early human trials: Phase II obesity trials showed some biological activity but failed to deliver meaningful weight-loss results at scale.[1]
  • Modern orthopaedic interest: Growing theoretical rationale, but a current lack of clinical trials in humans.[2]
  • Safety in humans: Long-term safety data are limited; unapproved use carries unknown risks.[4]

This is an area of active scientific curiosity, not established medicine. Nothing here should be taken as medical advice.

Curious About Dosage Ranges Used in Research?

If you are a researcher or simply want to understand the quantities studied in the literature, our AOD-9604 dosage chart breaks down the ranges seen across preclinical and clinical studies. You can also use our peptide calculator to explore research-grade dose conversions. All information is strictly for educational and research reference purposes.

Sources

  1. AOD-9604 Metabolic. — Current opinion in investigational drugs (London, England : 2000), 2004. PMID 15134286.
  2. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. — Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews, 2026. PMID 41490200.
  3. AOD-9604 does not influence the WADA hGH isoform immunoassay. — Drug testing and analysis, 2013. PMID 24124033.
  4. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. — Sports medicine (Auckland, N.Z.), 2026. PMID 41966639.
  5. Human sports drug testing by mass spectrometry. — Mass spectrometry reviews, 2017. PMID 26213263.
  6. Gateways to clinical trials. — Methods and findings in experimental and clinical pharmacology, 2005. PMID 15834452.
See the dosage chart — AOD-9604
A growth-hormone fragment studied for lipolysis without glycemic effects.
AOD-9604

FAQ

What is AOD-9604 made from?
AOD-9604 is a synthetic peptide — a short chain of amino acids — that mirrors the last 16 amino acids (positions 176–191) of human growth hormone. It is manufactured in a lab and is not extracted from any biological source. Because it is only a fragment of HGH, it behaves differently from the full hormone in the body.[1]
Has AOD-9604 been approved as a medicine?
No. AOD-9604 reached Phase II clinical trials as a potential obesity treatment but was never approved by any major regulatory body such as the FDA. It is currently classified as an unapproved compound. Researchers and sports medicine reviewers categorise it as part of a 'gray market' of peptides operating outside regulatory oversight.[4]
Will AOD-9604 show up on a drug test?
The standard WADA growth hormone immunoassay will not flag AOD-9604 as a positive result.[3] However, advanced mass spectrometry techniques used in elite anti-doping labs can detect peptide compounds in biological samples.[5] AOD-9604 is a banned substance under WADA rules regardless of detection method.
What are researchers most interested in studying AOD-9604 for today?
Current research interest has shifted toward musculoskeletal repair and recovery. Orthopaedic and sports medicine scientists are exploring whether AOD-9604 — alongside other peptides — can support tissue regeneration by activating IGF-1 signalling and satellite cell activity. However, clinical trials in humans are still lacking, and conclusions remain preliminary.[2][4]
For research and educational use only. Not medical advice.